We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mallinckrodt to Acquire Therakos for $1.325B

News   Aug 11, 2015

 
Mallinckrodt to Acquire Therakos for $1.325B
 
 
 

RELATED ARTICLES

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

Highly Effective and Selective Molecule Developed to Fight Malaria

News

A novel laboratory-synthesized molecule is a strong candidate for the development of a new antimalarial drug.

READ MORE

Key Role for Rare Lymphocyte in Inflammatory Arthritis

News

Immunologists have identified the key role of ILC2 during the onset of inflammatory arthritis which could open up new treatment approaches.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE